United Healthcare 2005 Annual Report Download - page 12

basis. Ingenix’s customers include more than 3,000 hospitals, 250,000 physicians, 2,000 payers and
intermediaries, more than 150 Fortune 500 companies, and more than 180 pharmaceutical and biotechnology
companies, as well as other UnitedHealth Group businesses. Ingenix is engaged in the simplification of health
care administration by providing products and services that help customers accurately and efficiently document,
code and bill for reimbursement for the delivery of care services. Ingenix is a leader in contract research services,
medical education services, publications, and pharmacoeconomics, outcomes, safety and epidemiology research
through its i3 businesses.
Ingenix’s products and services are sold primarily through a direct sales force focused on specific customers and
market segments across the pharmaceutical, biotechnology, employer, government, hospital, physician and payer
market segments. Ingenix’s products are also supported and distributed through an array of alliance and business
partnerships with other technology vendors, who integrate and interface its products with their applications.
The Ingenix companies are divided into two operating groups: information services and pharmaceutical services.
Information Services
Ingenix’s diverse product offerings help clients strengthen health care administration and advance health care
outcomes. These products include health care utilization reporting and analytics, physician clinical performance
benchmarking, clinical data warehousing, analysis and management responses for medical cost trends, decision-
support portals for evaluation of health benefits and treatment options and claims management tools for
administrative error and cost reduction. Ingenix uses proprietary software applications that manage clinical and
administrative data across diverse information technology environments. Ingenix also uses proprietary predictive
algorithmic applications to help clients detect and act on repetitive health care patterns in large data sets.
Ingenix provides other services on an outsourced basis, such as physician credentialing, provider directories,
HEDIS reporting, and fraud and abuse detection and prevention services. Ingenix also offers consulting services,
including actuarial and financial advisory work through its Reden & Anders division, as well as product
development, provider contracting and medical policy management. Ingenix publishes print and electronic media
products that provide customers with information regarding medical claims coding, reimbursement, billing and
compliance issues.
Pharmaceutical Services
Ingenix’s i3 division helps to coordinate and manage clinical trials for pharmaceutical products in development
for pharmaceutical, biotechnology and medical device manufacturers. Ingenix’s focus is to help pharmaceutical
and biotechnology customers effectively and efficiently get drug and medical device data to appropriate
regulatory bodies and to improve health outcomes through integrated information, analysis and technology.
Ingenix capabilities and efforts focus on the entire range of product assessment, through commercialization of
life-cycle management services—pipeline assessment, market access and product positioning, clinical trials,
economic, epidemiology, safety and outcomes research, and medical education. Ingenix services include global
contract research services, protocol development, investigator identification and training, regulatory assistance,
project management, data management, biostatistical analysis, quality assurance, medical writing and staffing
resource services. Ingenix’s pharmaceutical contract research operations are in 45 countries and are
therapeutically focused on oncology, the central nervous system, and respiratory and infectious diseases. Ingenix
uses comprehensive, science-based evaluation and analysis and benchmarking services to support
pharmaceutical, biotechnology and medical device development. Ingenix has developed an advanced drug
registry tool, i3 Aperio, that utilizes Ingenix’s proprietary research database to assist pharmaceutical
manufacturers and regulatory agencies in detecting potential safety issues from newly marketed drugs earlier
than other available surveillance methods. Ingenix also helps educate providers about pharmaceutical products
through medical symposia, product communications and scientific publications.
10